Blog & Case Studies
Background
A new active ingredient to Safapac was proposed to be manufactured in the form of a suspension concentrate (SC). The provided bill of materials (BOM) stated the required quantities of each component, but not a method of manufacture.
Lab to full scale
The BOM was broken down into how the separate components were to be used and whether they were to be used in intermediates or final products.
Laboratory Trial
From the BOM breakdown, a laboratory trial commenced using the above formulation protocol. Refinement was then made from the deduced laboratory findings of the small scale manufacturing results (evaluating chemical compatibility).Once the lab trial was complete, the sample underwent a storage stability protocol and samples were sent to the customer. At the end of the stability period, the samples were re-analysed and the results reported to the customer.
Plant Pilot Trial
The next stage was a pilot trial of 8,000L – before the trial could commence… continue reading